Chronic rhinosinusitis and antibiotics: The good, the bad, and the ugly

American Journal of Rhinology and Allergy

Volumn 27, Issue 6, 2013, Pages 467-472

  Kennedy, Joshua L ^a   Borish, Larry ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN E; SUPERANTIGEN; SURFACTANT;

ARTICLE; BIOFILM; BIOME; CHRONIC RHINOSINUSITIS; DISEASE SEVERITY; DOWN REGULATION; DRUG POTENCY; HUMAN; IMMUNE RESPONSE; OXYGEN CONCENTRATION; PH; STAPHYLOCOCCUS; SUPERINFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CHRONIC DISEASE; HUMANS; NASAL MUCOSA; RHINITIS; SINUSITIS; STAPHYLOCOCCUS; SUPERANTIGENS;

EID: 84890962955     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3960     Document Type: Article

References (61)

1. Lethbridge-Cejku MRD, and Vickerie J. Summary health statistics for U.S. adults: National Health Interview Survey, 2004. Hyattsville, MD: National Center for Health Statistics. Vital Health Stat 10:1-164, 2006.
2. Payne SC, Borish L, and Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 128:710-720, 2011.
3. Payne SC, Early SB, Huyett P, et al. Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope 121:2262-2267, 2011.
4. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 112:877-882, 2003.
5. Ponikau JU, Sherris DA, Kephart GM, et al. Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis. J Allergy Clin Immunol 116:362-369, 2005.
6. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 131:S1-S62, 2004.
7. Rachelefsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol 82:296-305, 1999.
8. Berges-Gimeno MP, Simon RA, and Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89:474-478, 2002.
9. Szczeklik A, and Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 55(suppl 2):S42-S44, 2000.
10. Szczeklik A, and Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis and management. J Allergy Clin Immunol 104:5-13, 1999.
11. Jacob A, Faddis BT, and Chole RA. Chronic bacterial rhinosinusitis: Description of a mouse model. Arch Otolaryngol Head Neck Surg 127:657-664, 2001.
12. Jones NS. CT of the paranasal sinuses: A review of the correlation with clinical, surgical and histopathological findings. Clin Otolaryngol Allied Sci 27:11-17, 2002.
13. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: From cytokines to growth. Am J Rhinol 14:279-290, 2000.
14. Stoop AE, van der Heijden HA, Biewenga J, and van der Baan S. Eosinophils in nasal polyps and nasal mucosa: An immunohistochemical study. J Allergy Clin Immunol 91:616-622, 1993.
15. Van Bruaene N, Derycke L, Perez-Novo CA, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 124:253-259, 2009.
16. Steinke JW, Payne SC, Tessier ME, et al. Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis. J Allergy Clin Immunol 124:1352-1354, e1357, 2009.
17. Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 22:34-37, 2008.
18. Kalish L, Snidvongs K, Sivasubramaniam R, et al. Topical steroids for nasal polyps. Cochrane Database Syst Rev 12:CD006549, 2012.
19. Parikh A, Scadding GK, Darby Y, and Baker RC. Topical corticosteroids in chronic rhinosinusitis: A randomized, double-blind, placebocontrolled trial using fluticasone propionate aqueous nasal spray. Rhinology 39:75-79, 2001.
20. Zadeh MH, Banthia V, Anand VK, and Huang C. Significance of eosinophilia in chronic rhinosinusitis. Am J Rhinol 16:313-317, 2002.
21. Costerton JW, Stewart PS, and Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 284:1318-1322, 1999.
22. Wood AJ, Fraser JD, Swift S, et al. Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune response. Am J Rhinol Allergy 26:265-270, 2012.
23. Bendouah Z, Barbeau J, Hamad WA, and Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991- 996, 2006.
24. Foreman A, Psaltis AJ, Tan LW, and Wormald PJ. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 23:556-561, 2009.
25. Prince AA, Steiger JD, Khalid AN, et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol 22:239-245, 2008.
26. Psaltis AJ, Weitzel EK, Ha KR, and Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 22:1-6, 2008.
27. Stewart PS, and Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138, 2001.
28. Antunes MB, Feldman MD, Cohen NA, and Chiu AG. Dose-dependent effects of topical tobramycin in an animal model of Pseudomonas sinusitis. Am J Rhinol 21:423-427, 2007.
29. Miller MB, and Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 55:165-199, 2001.
30. Sauer K, Camper AK, Ehrlich GD, et al. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184:1140-1154, 2002.
31. Hong W, Juneau RA, Pang B, and Swords WE. Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media. J Innate Immun 1:215-224, 2009.
32. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis: Skewing of T-cell receptor V beta-distributions in polyp-derived CD4+ and CD8+ T cells. Am J Rhinol 20:534-539, 2006.
33. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis II: Analysis of T-cell receptor V beta domains in nasal polyps. Am J Rhinol 20:451-455, 2006.
34. Hong SC, Waterbury G, and Janeway CA Jr. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor. J Exp Med 183:1437-1446, 1996.
35. Tripathi A, Kern R, Conley DB, et al. Staphylococcal exotoxins and nasal polyposis: Analysis of systemic and local responses. Am J Rhinol 19:327-333, 2005.
36. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 114:981-983, 2004.
37. Conley DB, Tripathi A, Ditto AM, et al. Chronic sinusitis with nasal polyps: Staphylococcal exotoxin immunoglobulin E and cellular inflammation. Am J Rhinol 18:273-278, 2004.
38. Bachert C, Zhang N, Holtappels G, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126:962-968, 2010.
39. Singhal D, Foreman A, Jervis-Bardy J, et al. Staphylococcus aureus biofilms: Nemesis of endoscopic sinus surgery. Laryngoscope 121: 1578-1583, 2011.
40. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-3269, 2003.
41. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 122:961-968, 2008.
42. Foreman A, Holtappels G, Psaltis AJ, et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy 66:1449-1456, 2011.
43. Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 125:52S-60S, 2004.
44. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: Two different approaches to treat nasal polyps. J Allergy Clin Immunol 125:1069-1076, 2010.
45. Labro MT. Anti-inflammatory activity of macrolides: A new therapeutic potential? J Antimicrob Chemother 41(suppl B):37-46, 1998.
46. Abreu NA, Nagalingam NA, Song Y, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med 4:151ra124, 2012.
47. Uren B, Psaltis A, and Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 118:1677-1680, 2008.
48. Jervis-Bardy J, Boase S, Psaltis A, et al. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope 122:2148-2153, 2012.
49. Valentine R, Jervis-Bardy J, Psaltis A, et al. Efficacy of using a hydrodebrider and of citric acid/zwitterionic surfactant on a Staphylococcus aureus bacterial biofilm in the sheep model of rhinosinusitis. Am J Rhinol Allergy 25:323-326, 2011.
50. Cohen M, Kofonow J, Nayak JV, et al. Biofilms in chronic rhinosinusitis: A review. Am J Rhinol Allergy 23:255-260, 2009.
51. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and non-allergic patients with nasal polyps and asthma. J Allergy Clin Immunol 129:AB69, 2012.
52. Zhang N, Holtappels G, Gevaert P, et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 66:141-148, 2011.
53. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131:110-116.e1, 2013.
54. Flood-Page PT, Menzies-Gow AN, Kay AB, and Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167:199-204, 2003.
55. Baroody FM, Mucha SM, Detineo M, et al. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol 121:1126-1132, 2008.
56. Baroody FM, Mucha SM, deTineo M, and Naclerio RM. Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg 146:880-886, 2012.
57. Braccioni F, Dorman SC, O'Byrne PM, et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 110:96-101, 2002.
58. Mochizuki A, Tamura N, Yatabe Y, et al. Suppressive effects of F-1322 on the antigen-induced late asthmatic response and pulmonary eosinophilia in guinea pigs. Eur J Pharmacol 430:123-133, 2001.
59. Harvey RJ, Goddard JC, Wise SK, and Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg 139:137-142, 2008.
60. Grobler A, Weitzel EK, Buele A, et al. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope 118:2078-2081, 2008.
61. Mascia K, Borish L, Patrie J, et al. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 94:652-657, 2005.